Authors: Boswell, FJ Andrews, JM Wise, R

Citation: Fj. Boswell et al., Comparison of the in vitro activities of BMS-284756 and four fluoroquinolones against Streptococcus pneumoniae, J ANTIMICRO, 48(3), 2001, pp. 446-447

Authors: Andrews, JM Boswell, FJ Wise, R

Citation: Jm. Andrews et al., Evaluation of the Oxoid Aura image system for measuring zones of inhibition with the disc diffusion technique, J ANTIMICRO, 46(4), 2000, pp. 535-540

Authors: Andrews, JM Boswell, FJ Wise, R

Citation: Jm. Andrews et al., Establishing MIC breakpoints for coagulase-negative staphylococci to oxacillin, J ANTIMICRO, 45(2), 2000, pp. 259-261

Authors: Boswell, FJ Andrews, JM Wise, R Dalhoff, A

Citation: Fj. Boswell et al., Bactericidal properties of moxifloxacin and post-antibiotic effect, J ANTIMICRO, 43, 1999, pp. 43-49

Authors: Boswell, FJ Andrews, JM Ashby, JP Fogarty, C Brenwald, NP Wise, R

Citation: Fj. Boswell et al., The in-vitro activity of HMR 3647, a new ketolide antimicrobial agent, J ANTIMICRO, 42(6), 1998, pp. 703-709

Authors: Wise, R Andrews, JM Boswell, FJ Ashby, JP

Citation: R. Wise et al., The in-vitro activity of linezolid (U-100766) and tentative breakpoints, J ANTIMICRO, 42(6), 1998, pp. 721-728